No abstract available
Keywords:
drug industry; drug repurposing; government regulation; nelivaptan; shelved compounds; tax incentives.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antidiuretic Hormone Receptor Antagonists / therapeutic use
-
Anxiety Disorders / drug therapy
-
Depressive Disorder, Major / drug therapy
-
Drug Industry
-
Drug Repositioning* / methods
-
Humans
-
Indoles / therapeutic use
-
Pyrrolidines / therapeutic use
-
Receptors, Vasopressin / therapeutic use
Substances
-
1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide
-
AVPR1b protein, human
-
Antidiuretic Hormone Receptor Antagonists
-
Indoles
-
Pyrrolidines
-
Receptors, Vasopressin